Effect of Mantra Chikitsa on Pregnancy and Newborn Baby

Phase 1

Not yet recruiting

• Conditions: Health Condition 1: O28- Abnormal findings on antenatal screening of motherHealth Condition 2: O00-O9A- Pregnancy, childbirth and the puerperium

• Registration Number: CTRI/2023/05/053135
• Lead Sponsor: Banaras Hindu University

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Last Update Posted: 18 September 2023

Recruitment & Eligibility

• Status: Not Yet Recruiting
• Sex: Not specified
• Target Recruitment: 0

Inclusion Criteria

1. All Nulliparous and Multiparous women of 20-32 years of age attending the Prasuti Tantra OPD at 6-8 weeks of Pregnancy with single live intrauterine pregnancy. Gestational age will be based on clinical findings and 1st-trimester USG (obs) scan.

2. Pregnant women without serious co-morbidities or risks associated with pregnancy.

Exclusion Criteria

1. Pregnant women with profound hearing loss.

2. Pregnant women have systemic diseases like Diabetes mellitus(DM), Hypertension (HTN), Tuberculosis (TB), heart diseases, severe anaemia, chronic and acute liver and renal diseases, jaundice, coagulation disorders etc.

3. Pregnant women have a history of a genetic disorder in the family.

4. Multiple pregnancies

5. Psychiatric patient or history of bipolar disorder, depression, anxiety and any other psychological disorders which require medications.

6. Pregnant women have an addiction history to alcohol and drugs.

7. Drug history of prolonged steroid medication.

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
1. Reduction of maternal anxiety during pregnancy. <br/ ><br>2. Reduction of post-natal depression <br/ ><br>3. Study of Neonatal Neurobehaviour. <br/ ><br>4. Study of the effect of Mantra Therapy on feto-maternal attachment during pregnancy and mother or child bonding after delivery. <br/ ><br>5. Effect of Mantra Therapy on Uterine Artery Colour Doppler Indices <br/ ><br>6. evaluate the effect of Mantra Therapy on Placental gene expression of NR3C1 and HSD11B2 <br/ ><br>Timepoint: 1. 6-8,10-12, 14-16, 18-20, 22-24, 26-28, 30-32, 34-36, 38-40 weeks of pregnancy <br/ ><br>2. During labor <br/ ><br>3. 3rd, 7th, 15th, 30th post-partum day